Ország: Malajzia
Nyelv: angol
Forrás: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
DEXCHLORPHENIRAMINE MALEATE
DUOPHARMA MANUFACTURING (BANGI) SDN BHD
DEXCHLORPHENIRAMINE MALEATE
90 ml
DUOPHARMA MANUFACTURING (BANGI) SDN BHD
_Consumer Medication Information Leaflet (RIMUP) _ 1 DEXCHLORAMINE SYRUP Dexchlorpheniramine Maleate (2mg/5ml) WHAT IS IN THE LEAFLET? 1. What Dexchloramine is used for 2. How Dexchloramine works 3. Before you use Dexchloramine 4. How to use Dexchloramine 5. While you are using it 6. Side effects 7. Storage and Disposal of Dexchloramine 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of Revision WHAT DEXCHLORAMINE IS USED FOR Dexchloramine is used to prevent and treat allergies including: • perennial (occurs year- round) and seasonal allergic rhinitis (allergic inflammation of the nasal airways) • vasomotor rhinitis (runny nose that is not due to allergy) • allergic conjunctivitis (inflammation of the membrane covering the eye) • pruritus (itching) due to allergic reaction • urticaria (a raised, itchy rash on skin. Ask your doctor if you have any questions about why this medicine has been prescribed for you. Your doctor may have prescribed this medicine for another reason. HOW DEXCHLORAMINE WORKS The name of your medicine is Dexchloramine. It contains the active ingredient dexchlorpheniramine maleate which is an antihistamine. Histamine is a chemical released into the body during an allergic reaction. It causes itching and inflammation. Dexchloramine works by blocking the effects of histamine, calming down the body's allergic reaction and starting to relieve the symptoms. BEFORE YOU USE DEXCHLORAMINE - _When you must not use it _ Do not take this medicine if: • you are hypersensitive to, or have had an allergic reaction to dexchlorpheniramine or any of the ingredients listed at the end of this leaflet. • you are taking a class of medicine known as monoamine oxidase inhibitors (MAOIs) (often taken for depression), or you have taken such a medicine within the last 14 days. • the expiry date (EXP) printed on the pack has passed. • the packaging is torn, shows signs of tampering or it does not look quite right. - _Before you start to use it _ You must tell your doctor Olvassa el a teljes dokumentumot
52 BASE 52mm x 112mm Glue Glue Spine 62 5 22 32 5 4 52 FRONT 52mm x 329mm Glue 37 7 27 32 32 31 31 32 2 5 4th Fold 3rd Fold 2nd Fold 1st Fold 52 INSIDE 52mm x 329mm Glue 37 32 32 32 31 31 32 5 2 2 KEEP CONTAINER TIGHTLY CLOSED. PROTECT FROM LIGHT. STORE IN A DRY PLACE BELOW 30°C. KEEP OUT OF REACH OF CHILDREN JAUHKAN DARIPADA KANAK-KANAK. FOR INKJET PRINTING: LOT MFG EXP 25MM(W) X 15MM(H) include hypotension, headache and paraesthesia. CONTRAINDICATIONS Dexchlorpheniramine should not be given to premature infants or neonates: this group of patients has an increased susceptibility to antimuscarinic effects. Dexchlorpheniramine should not be given to patients receiving MAO inhibitor therapy and to patients who have shown a previous hypersensitivity. PRECAUTIONS The anticholinergic properties of dexchlorpheniramine may cause drowsiness, dizziness, blurred vision and psychomotor impairment in some patients which may seriously affect ability to drive or operate machinery. Anticholinergic effects may also precipitate or aggravate urinary retention in patients with bladder neck obstruction, symptomatic prostatic hypertrophy and predisposition to urinary retention. Increased intraocular pressure may precipitate an attack of angle-closure glaucoma. Dexchlorpheniramine should be used with care in patients with pyloroduodenal obstruction, severe cardiovascular disorders and epilepsy. Patients sensitive to one antihistamine may be sensitive to dexchlorpheniramine as well. Antihistamines may inhibit the cutaneous histamine response, thus producing false-negative results; it is recommended that dexchlorpheniramine be discontinued at least 72 hours before testing begins. DRUG INTERACTION Concurrent use with alcohol and CNS depressants such as barbiturates, hypnotics, opioid analgesics, monoamine oxidase (MAO) inhibitors, anxiolytic sedatives and neuroleptics may potentiate the CNS depressant effects. Anticholinergic effects may be potentiated when these medications such as atropine, tricyclic antidepressants and MAO inhibitors Olvassa el a teljes dokumentumot